Investor Overview

Update
Headquarters:
Ingelheim Am Rhein

Venture Capital Firm

Description

Update

Our primary aim is to activate success for those companies and entrepreneurs we support and to earn a reputation as a long-term trusted partner. Beyond capital investment, we intend to take an active role with our portfolio companies – delivering significant added value through our own extensive drug discovery, scientific and managerial expertise and access to selected relevant experts and knowledge. Nevertheless, we also attach significant importance to confidentiality, establishing ethical walls to protect our portfolio companies and entrepreneurs.

Our sole focus is to search for significant enhancements in patient care through innovative and pioneering science including (but not limited to):

- Address "undrugable" targets, e.g. targets that are poorly amendable to either current NCEs or NBEs - Next generation vaccines, e.g. T-Cell vaccines - Next generation NBEs, e.g. cancer immunotherapeutics -... See More

Current Team (4)

Update

Investments (6)

Update

Offices/Locations (1)

Update
  • Headquarters

    Binger Strasse 173

    Ingelheim Am Rhein, D-55216

    DEU